img

Global Inactivated Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inactivated Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Inactivated Influenza Vaccine market is projected to reach US$ 10610 million in 2029, increasing from US$ 6990 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2029. Demand from Children and Adolescence are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inactivated Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Changchun Institute of Biological
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application


Children
Adolescence
Adults
Elderly

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Inactivated Influenza Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inactivated Influenza Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inactivated Influenza Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Inactivated Influenza Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inactivated Influenza Vaccine introduction, etc. Inactivated Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Inactivated Influenza Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Inactivated Influenza Vaccine Market Overview
1.1 Inactivated Influenza Vaccine Product Overview
1.2 Inactivated Influenza Vaccine Market Segment by Type
1.2.1 Trivalent Influenza Vaccine
1.2.2 Quadrivalent Influenza Vaccine
1.3 Global Inactivated Influenza Vaccine Market Size by Type
1.3.1 Global Inactivated Influenza Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Inactivated Influenza Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Inactivated Influenza Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inactivated Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Inactivated Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Inactivated Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Inactivated Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Inactivated Influenza Vaccine Sales Breakdown by Type (2018-2024)
2 Global Inactivated Influenza Vaccine Market Competition by Company
2.1 Global Top Players by Inactivated Influenza Vaccine Sales (2018-2024)
2.2 Global Top Players by Inactivated Influenza Vaccine Revenue (2018-2024)
2.3 Global Top Players by Inactivated Influenza Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Inactivated Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inactivated Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Inactivated Influenza Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Inactivated Influenza Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Inactivated Influenza Vaccine Market
2.8 Key Manufacturers Inactivated Influenza Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inactivated Influenza Vaccine Status and Outlook by Region
3.1 Global Inactivated Influenza Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inactivated Influenza Vaccine Historic Market Size by Region
3.2.1 Global Inactivated Influenza Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Inactivated Influenza Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Inactivated Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Inactivated Influenza Vaccine Forecasted Market Size by Region
3.3.1 Global Inactivated Influenza Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Inactivated Influenza Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Inactivated Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inactivated Influenza Vaccine by Application
4.1 Inactivated Influenza Vaccine Market Segment by Application
4.1.1 Children
4.1.2 Adolescence
4.1.3 Adults
4.1.4 Elderly
4.2 Global Inactivated Influenza Vaccine Market Size by Application
4.2.1 Global Inactivated Influenza Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Inactivated Influenza Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Inactivated Influenza Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inactivated Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Inactivated Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Inactivated Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Inactivated Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Inactivated Influenza Vaccine Sales Breakdown by Application (2018-2024)
5 North America Inactivated Influenza Vaccine by Country
5.1 North America Inactivated Influenza Vaccine Historic Market Size by Country
5.1.1 North America Inactivated Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inactivated Influenza Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Inactivated Influenza Vaccine Sales in Value by Country (2018-2024)
5.2 North America Inactivated Influenza Vaccine Forecasted Market Size by Country
5.2.1 North America Inactivated Influenza Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Inactivated Influenza Vaccine Sales in Value by Country (2024-2029)
6 Europe Inactivated Influenza Vaccine by Country
6.1 Europe Inactivated Influenza Vaccine Historic Market Size by Country
6.1.1 Europe Inactivated Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inactivated Influenza Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Inactivated Influenza Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Inactivated Influenza Vaccine Forecasted Market Size by Country
6.2.1 Europe Inactivated Influenza Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Inactivated Influenza Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Inactivated Influenza Vaccine by Region
7.1 Asia-Pacific Inactivated Influenza Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Inactivated Influenza Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inactivated Influenza Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Inactivated Influenza Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Inactivated Influenza Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Inactivated Influenza Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inactivated Influenza Vaccine Sales in Value by Region (2024-2029)
8 Latin America Inactivated Influenza Vaccine by Country
8.1 Latin America Inactivated Influenza Vaccine Historic Market Size by Country
8.1.1 Latin America Inactivated Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inactivated Influenza Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Inactivated Influenza Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Inactivated Influenza Vaccine Forecasted Market Size by Country
8.2.1 Latin America Inactivated Influenza Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inactivated Influenza Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Inactivated Influenza Vaccine by Country
9.1 Middle East and Africa Inactivated Influenza Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Inactivated Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inactivated Influenza Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Inactivated Influenza Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Inactivated Influenza Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Inactivated Influenza Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inactivated Influenza Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL Limited
10.1.1 CSL Limited Company Information
10.1.2 CSL Limited Introduction and Business Overview
10.1.3 CSL Limited Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CSL Limited Inactivated Influenza Vaccine Products Offered
10.1.5 CSL Limited Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Inactivated Influenza Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Company Information
10.3.2 Sanofi Pasteur Introduction and Business Overview
10.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Products Offered
10.3.5 Sanofi Pasteur Recent Development
10.4 Viatris
10.4.1 Viatris Company Information
10.4.2 Viatris Introduction and Business Overview
10.4.3 Viatris Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Viatris Inactivated Influenza Vaccine Products Offered
10.4.5 Viatris Recent Development
10.5 Hualan Biological
10.5.1 Hualan Biological Company Information
10.5.2 Hualan Biological Introduction and Business Overview
10.5.3 Hualan Biological Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Hualan Biological Inactivated Influenza Vaccine Products Offered
10.5.5 Hualan Biological Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AstraZeneca Inactivated Influenza Vaccine Products Offered
10.6.5 AstraZeneca Recent Development
10.7 Sinovac Biotech
10.7.1 Sinovac Biotech Company Information
10.7.2 Sinovac Biotech Introduction and Business Overview
10.7.3 Sinovac Biotech Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sinovac Biotech Inactivated Influenza Vaccine Products Offered
10.7.5 Sinovac Biotech Recent Development
10.8 Aleph Biomedical
10.8.1 Aleph Biomedical Company Information
10.8.2 Aleph Biomedical Introduction and Business Overview
10.8.3 Aleph Biomedical Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Aleph Biomedical Inactivated Influenza Vaccine Products Offered
10.8.5 Aleph Biomedical Recent Development
10.9 Abbott Laboratories
10.9.1 Abbott Laboratories Company Information
10.9.2 Abbott Laboratories Introduction and Business Overview
10.9.3 Abbott Laboratories Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Abbott Laboratories Inactivated Influenza Vaccine Products Offered
10.9.5 Abbott Laboratories Recent Development
10.10 Novartis International
10.10.1 Novartis International Company Information
10.10.2 Novartis International Introduction and Business Overview
10.10.3 Novartis International Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis International Inactivated Influenza Vaccine Products Offered
10.10.5 Novartis International Recent Development
10.11 Changchun Institute of Biological
10.11.1 Changchun Institute of Biological Company Information
10.11.2 Changchun Institute of Biological Introduction and Business Overview
10.11.3 Changchun Institute of Biological Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Changchun Institute of Biological Inactivated Influenza Vaccine Products Offered
10.11.5 Changchun Institute of Biological Recent Development
10.12 BCHT
10.12.1 BCHT Company Information
10.12.2 BCHT Introduction and Business Overview
10.12.3 BCHT Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 BCHT Inactivated Influenza Vaccine Products Offered
10.12.5 BCHT Recent Development
10.13 Jiangsu GDK
10.13.1 Jiangsu GDK Company Information
10.13.2 Jiangsu GDK Introduction and Business Overview
10.13.3 Jiangsu GDK Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jiangsu GDK Inactivated Influenza Vaccine Products Offered
10.13.5 Jiangsu GDK Recent Development
10.14 KM Biologics
10.14.1 KM Biologics Company Information
10.14.2 KM Biologics Introduction and Business Overview
10.14.3 KM Biologics Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 KM Biologics Inactivated Influenza Vaccine Products Offered
10.14.5 KM Biologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inactivated Influenza Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inactivated Influenza Vaccine Industrial Chain Analysis
11.4 Inactivated Influenza Vaccine Market Dynamics
11.4.1 Inactivated Influenza Vaccine Industry Trends
11.4.2 Inactivated Influenza Vaccine Market Drivers
11.4.3 Inactivated Influenza Vaccine Market Challenges
11.4.4 Inactivated Influenza Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inactivated Influenza Vaccine Distributors
12.3 Inactivated Influenza Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Trivalent Influenza Vaccine
Table 2. Major Company of Quadrivalent Influenza Vaccine
Table 3. Global Inactivated Influenza Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Inactivated Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Inactivated Influenza Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Inactivated Influenza Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Inactivated Influenza Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Inactivated Influenza Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Inactivated Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Inactivated Influenza Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Inactivated Influenza Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Inactivated Influenza Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Inactivated Influenza Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Inactivated Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Inactivated Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Inactivated Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Inactivated Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Inactivated Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Inactivated Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Inactivated Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Inactivated Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Inactivated Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Inactivated Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Inactivated Influenza Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Inactivated Influenza Vaccine Sales Share by Company (2018-2024)
Table 26. Global Inactivated Influenza Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Inactivated Influenza Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Inactivated Influenza Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Inactivated Influenza Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Inactivated Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Influenza Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Inactivated Influenza Vaccine Market
Table 33. Key Manufacturers Inactivated Influenza Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Inactivated Influenza Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Inactivated Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Inactivated Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Inactivated Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Inactivated Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Inactivated Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Inactivated Influenza Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Inactivated Influenza Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Inactivated Influenza Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Inactivated Influenza Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Inactivated Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Inactivated Influenza Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Inactivated Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Inactivated Influenza Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Inactivated Influenza Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Inactivated Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Inactivated Influenza Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Inactivated Influenza Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Inactivated Influenza Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Inactivated Influenza Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Inactivated Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Inactivated Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Inactivated Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Inactivated Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Inactivated Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Inactivated Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Inactivated Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Inactivated Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Inactivated Influenza Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Inactivated Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Inactivated Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Inactivated Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Inactivated Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Inactivated Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Inactivated Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Inactivated Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Inactivated Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Inactivated Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Inactivated Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Inactivated Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Inactivated Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Inactivated Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Inactivated Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Inactivated Influenza Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Inactivated Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Inactivated Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Inactivated Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Inactivated Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Inactivated Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. CSL Limited Company Information
Table 108. CSL Limited Introduction and Business Overview
Table 109. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. CSL Limited Inactivated Influenza Vaccine Product
Table 111. CSL Limited Recent Development
Table 112. GSK Company Information
Table 113. GSK Introduction and Business Overview
Table 114. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. GSK Inactivated Influenza Vaccine Product
Table 116. GSK Recent Development
Table 117. Sanofi Pasteur Company Information
Table 118. Sanofi Pasteur Introduction and Business Overview
Table 119. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Pasteur Inactivated Influenza Vaccine Product
Table 121. Sanofi Pasteur Recent Development
Table 122. Viatris Company Information
Table 123. Viatris Introduction and Business Overview
Table 124. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Viatris Inactivated Influenza Vaccine Product
Table 126. Viatris Recent Development
Table 127. Hualan Biological Company Information
Table 128. Hualan Biological Introduction and Business Overview
Table 129. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Hualan Biological Inactivated Influenza Vaccine Product
Table 131. Hualan Biological Recent Development
Table 132. AstraZeneca Company Information
Table 133. AstraZeneca Introduction and Business Overview
Table 134. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. AstraZeneca Inactivated Influenza Vaccine Product
Table 136. AstraZeneca Recent Development
Table 137. Sinovac Biotech Company Information
Table 138. Sinovac Biotech Introduction and Business Overview
Table 139. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Sinovac Biotech Inactivated Influenza Vaccine Product
Table 141. Sinovac Biotech Recent Development
Table 142. Aleph Biomedical Company Information
Table 143. Aleph Biomedical Introduction and Business Overview
Table 144. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Aleph Biomedical Inactivated Influenza Vaccine Product
Table 146. Aleph Biomedical Recent Development
Table 147. Abbott Laboratories Company Information
Table 148. Abbott Laboratories Introduction and Business Overview
Table 149. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Abbott Laboratories Inactivated Influenza Vaccine Product
Table 151. Abbott Laboratories Recent Development
Table 152. Novartis International Company Information
Table 153. Novartis International Introduction and Business Overview
Table 154. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Novartis International Inactivated Influenza Vaccine Product
Table 156. Novartis International Recent Development
Table 157. Changchun Institute of Biological Company Information
Table 158. Changchun Institute of Biological Introduction and Business Overview
Table 159. Changchun Institute of Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Changchun Institute of Biological Inactivated Influenza Vaccine Product
Table 161. Changchun Institute of Biological Recent Development
Table 162. BCHT Company Information
Table 163. BCHT Introduction and Business Overview
Table 164. BCHT Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. BCHT Inactivated Influenza Vaccine Product
Table 166. BCHT Recent Development
Table 167. Jiangsu GDK Company Information
Table 168. Jiangsu GDK Introduction and Business Overview
Table 169. Jiangsu GDK Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Jiangsu GDK Inactivated Influenza Vaccine Product
Table 171. Jiangsu GDK Recent Development
Table 172. KM Biologics Company Information
Table 173. KM Biologics Introduction and Business Overview
Table 174. KM Biologics Inactivated Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. KM Biologics Inactivated Influenza Vaccine Product
Table 176. KM Biologics Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Inactivated Influenza Vaccine Market Trends
Table 180. Inactivated Influenza Vaccine Market Drivers
Table 181. Inactivated Influenza Vaccine Market Challenges
Table 182. Inactivated Influenza Vaccine Market Restraints
Table 183. Inactivated Influenza Vaccine Distributors List
Table 184. Inactivated Influenza Vaccine Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Influenza Vaccine Product Picture
Figure 2. Global Inactivated Influenza Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inactivated Influenza Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Inactivated Influenza Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Trivalent Influenza Vaccine
Figure 6. Global Trivalent Influenza Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Quadrivalent Influenza Vaccine
Figure 8. Global Quadrivalent Influenza Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Inactivated Influenza Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Inactivated Influenza Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Inactivated Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Inactivated Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Inactivated Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Inactivated Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Inactivated Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Inactivated Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Influenza Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Influenza Vaccine Revenue in 2022
Figure 23. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Children
Figure 25. Global Children Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Adolescence
Figure 27. Global Adolescence Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Adults
Figure 29. Global Adults Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Elderly
Figure 31. Global Elderly Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Inactivated Influenza Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Inactivated Influenza Vaccine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Inactivated Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Inactivated Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Inactivated Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Inactivated Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Inactivated Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Inactivated Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Inactivated Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Inactivated Influenza Vaccine Manufacturing Cost Structure
Figure 45. Inactivated Influenza Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries